Transcription of Valuation and Deal Structuring
{{id}} {{{paragraph}}}
Example: dental hygienist
Valuation and Deal Structuring
Valuation and Deal StructuringValuation and Deal StructuringBIO sAdvanced Business Development CourseJune 2015 Prepared for:Joe DillonPresident Bringing money to medicine DILLONCAPITALSTRATEGIESDILLONCAPITALSTRA TEGIESC opyright , , ,theinformationinthisworkhasbeenobtained fromavarietyofsourcesand,assuch,allstate ments,facts,information,analyses,interpr etations,andopinionscontainedinthereport areprovided AsIs andaremadewithoutrepresentationorwarrant yofanykindbycourseorganizersortheAuthors astoaccuracy,completeness,usefulness,mer chantability,fitnessforaparticularpurpos e, Word from the AttorneysDILLONCAPITALSTRATEGIES408.
M&A Mania –M&As by value up, 168% from 2013, even eclipsed the recent high in 2009. Allergan deal and commercial consolidation dominated. Biotech less than 10% of this volume. Number of Biotech Out-licensing Deals –Still running flat compared to recent years. Value of those Deals –Continued climb in valuations from already healthy levels.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: